Literature DB >> 16237985

Brachytherapy with gamma radiation of a coronary artery for in-stent restenosis may induce the regression of in-stent restenosis of an adjacent coronary artery without angioplasty. First case report and review of the literature.

Mohammad-Reza Movahed1.   

Abstract

Here, we present a case of a 63-year-old male who presented with in-stent restenosis of two coronary arteries simultaneously (mid circumflex and proximal ramus). After the brachytherapy of the circumflex artery for in-stent restenosis, the patient refused the staged procedure for the ramus in-stent restenosis. After approximately 2 years, the patient underwent coronary angiography for recurrent chest pain. Surprisingly, the proximal ramus stent showed marked regression of in-stent restenosis. We hypothesized that the gamma brachytherapy of the circumflex artery could have induced the regression of in-stent restenosis of the adjacent ramus artery due to the deep tissue penetration of gamma radiation. Based on our observation, we believe that in the treatment of in-stent restenosis of a coronary artery, the initial balloon angioplasty may not be as important as the radiation itself. This observation warrants further study to evaluate the effect of external or internal radiation on in-stent restenosis without balloon angioplasty. If our hypothesis is confirmed, the treatment of in-stent restenosis with external radiation could substantially simplify the treatment of this disease. This case report follows a brief review of the literature.

Entities:  

Mesh:

Year:  2004        PMID: 16237985     DOI: 10.1016/j.carrev.2005.02.003

Source DB:  PubMed          Journal:  Cardiovasc Radiat Med        ISSN: 1522-1865


  1 in total

1.  In vitro study on the feasibility of magnetic stent hyperthermia for the treatment of cardiovascular restenosis.

Authors:  Li Li; Rui Wang; Huan-Huan Shi; LE Xie; Jing-Ding-Sha Li; Wei-Chao Kong; Jin-Tian Tang; DA-Nian Ke; Ling-Yun Zhao
Journal:  Exp Ther Med       Date:  2013-06-21       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.